Payment of Retention Fees for the Year Ending 31 December 2025

Your attention is drawn to the provisions of the Medicines and Related Substances Act, 101 of 1965, as amended, which provide for the payment of retention fees to the South African Health Products Regulatory Authority (SAHPRA) in respect of medicines registered and medical devices, including in vitro devices (IVDs), establishment licenses issued. These retention fees are payable on or before the last working day of 30 June that year, failing which the registration or licence may be cancelled.